| Optaflu, Injektionssuspension - 0.5 ml | | 58271007 | | Novartis Pharma Schweiz AG | | Optaflu, Injektionssuspension | | 28.05.2009 | | | | | 28.05.2009 | | Influenza, gereinigtes Antigen (J07BB02) | | | | WHO-DDD | | 27.05.2019 | | 08.08. | | 0.5 ml | | 08.08. | | | | B | | | | Nein | | | | FI | | | | 10.05 | | | | k.A. | | 19.70 | | FB | | | | 7680582710073 | | Impfstoffe | | | | |
| | Zusammensetzung | | haemagglutininum influenzae A (H1N1) (A/New Caledonia/20/99 - like Reass., IVR-116) 15 µg, haemagglutininum influenzae A (H3N2) (A/California/7/2004 - like NYMC X-157) 15 µg, haemagglutininum influenzae B (Shanghai/361/2002 -like B/Jiangsu/10/2003) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | | Quelle | | | |
|
|
